Skip to main content
. 2019 Nov 20;14(11):e0218299. doi: 10.1371/journal.pone.0218299

Table 1. Demographic and clinical characteristics of 2269 patients with MDR-TB and XDR-TB.

Characteristics Total of patients (%) MDR-TB (%) XDR-TB (%) p-value *
N = 2269 N = 2129 N = 140
Sex
Female 803 (35.4) 758 (35.6) 45 (35.4) 0.407
Male 1466 (64.4) 1371 (64.4) 95 (67.9)
Age Range
0–24 345 (15.2) 329 (15.5) 16 (11.4) 0.310
25–44 1126 (49.6) 1047 (49.2) 79 (56.4)
45–64 715 (31.5) 676 (31.8) 39 (27.9)
≥65 83 (3.7) 77 (3.6) 6 (4.3)
Ethnical group
Caucasian 816 (36.0) 762 (35.8) 54 (38.6) 0.484
Afro-Brazilian 1372 (60.5) 1290 (60.6) 82 (58.6)
Unknown 81 (3.5) 77 (3.6) 4 (2.8)
Years of study
None 113 (5.0) 109 (5.1) 4 (2.9) 0.221
1 a 3 430 (19.0) 405 (19.0) 25 (17.9)
4 a 7 879 (38.7) 828 (38.9) 51 (36.4)
8 a 11 491 (21.6) 450 (21.1) 41 (29.3)
≥12 166 (7.3) 155 (7.3) 11 (7.9)
Unknown 190 (8.4) 182 (8.6) 8 (5.7)
Site of disease
Extrapulmonary 20 (0.9) 20 (0.9) 0 0.403
Pulmonary 2218 (97.7) 2079 (97.7) 139 (99.3)
Both 31 (1.4) 30 (1.4) 1 (0.8)
HIV status (n = 2103)
Negative 1936 (92.1) 1826 (92.2) 110 (90.1) 0.425
Positive 167 (7.9) 155 (7.8) 12 (9.8)
Risk factors
Diabetes 219 (9.6) 200 (9.4) 19 (13.5) 0.105
Alcohol abuse 269 (11.9) 257 (12.1) 12 (8.6) 0.215
Drug use 179 (7.9) 167 (7.8) 12 (8.6) 0.757
Smoking 188 (8.3) 175 (8.2) 13 (9.3) 0.658
Prisoner 36 (1.6) 36 (1.7) 0 0.121
Unemployed 373 (16.4) 344 (16.2) 29 (20.7) 0.159
Comorbidities 247 (11.7) 229 (11.6) 18 (14.1) 0.391
Chest radiography (n = 2191)
Cavitation 1772 (80.9) 1652 (80.4) 120 (88.2) 0.024
Bilateral 1648 (75.3) 1531 (74.6) 117 (86.0) 0.003
Resistance type
Primary 334 (14.7) 324 (15.2) 10 (7.1) 0.009
Acquired 1935 (85.3) 1805 (84.8) 130 (92.9)
Previous MDR-TB treatments
No 1744 (76.9) 1703 (80.0) 41 (29.3) <0.001
Yes 525 (23.1) 426 (20.0) 99 (70.7)

TB = tuberculosis; MDR-TB = multidrug-resistant TB; XDR-TB = extensively drug-resistant TB

HIV = human immunodeficiency virus.

*Comparison between MDR/XDR-TB.

Except Diabetes and HIV.